Scott E. Counts, Ph.D.

Emory University, Atlanta, GA 
"Scott Counts"
Mean distance: 18.03 (cluster 11)


Sign in to add mentor
Allan I. Levey grad student 2000 Emory
 (Regulation of Alzheimer's presenilin -1 by nerve growth factor.)


Sign in to add trainee
Jessica S. Fortin research scientist 2020- Michigan State (Chemistry Tree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mufson EJ, Ikonomovic MD, Counts SE, et al. (2016) Molecular and Cellular Pathophysiology of Preclinical Alzheimer's Disease. Behavioural Brain Research
Tiernan CT, Ginsberg SD, Guillozet-Bongaarts AL, et al. (2016) Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease. Neurobiology of Aging. 42: 80-90
Weinberg RB, Mufson EJ, Counts SE. (2015) Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment. Frontiers in Neuroscience. 9: 430
Mufson EJ, Mahady L, Waters D, et al. (2015) Hippocampal plasticity during the progression of Alzheimer's disease. Neuroscience
Counts SE, Perez SE, He B, et al. (2014) Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease. Current Alzheimer Research. 11: 655-63
Counts SE, Lahiri DK. (2014) Overview of immunotherapy in Alzheimer's disease (AD) and mechanisms of IVIG neuroprotection in preclinical models of AD. Current Alzheimer Research. 11: 623-5
Counts SE, Ray B, Mufson EJ, et al. (2014) Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease. Journal of Clinical Immunology. 34: S80-5
Counts SE, Alldred MJ, Che S, et al. (2014) Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology. 79: 172-9
Fonseca MI, McGuire SO, Counts SE, et al. (2013) Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology. Journal of Neuroinflammation. 10: 25
Mufson EJ, He B, Nadeem M, et al. (2012) Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 71: 1018-29
See more...